from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv2587c/secD

LFCtreatmentdescriptionclass of inhibitor

-1.581

Amikacinug/mL Amikacintranslation

-2.090

Cap5-10ug/mL Capreomycintranslation

-2.720

Rox10-50 ug/mL Roxithromycintranslation

-0.315

SM2-5 ug/mL Streptomycintranslation

-3.292

Tet5-10 ug/mL Tetracyclinetranslation

0.568

Rif0.2-5ug/mL Rifampicintranscription

-0.513

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.339

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-1.746

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

1.282

CPZ10-50 ug/mL Chlorpromazinerespiration

0.549

Clofazimine10-13 ug/mL Clofaziminerespiration

0.640

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-0.633

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-1.510

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.371

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.584

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.332

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

1.489

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.778

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.072

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

0.521

KCN5-20 ug/mL Potassium cyaniderespiration

0.230

NaN30.2-2 mM Sodium aziderespiration

-0.177

Nigericin50 uM Nigericinrespiration

-1.229

TRC10-150 ug/mL Triclosanrespiration

0.039

TRZ10-25 ug/mL Thioridazinerespiration

-1.930

Valinomycin0.5-10 uM Valinomycinrespiration

0.451

ZnSO42 mM ZnSO4respiration

-0.082

menadione6-10 ug/mL Menadionerespiration

0.367

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.017

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.149

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.026

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.561

NRP_1Non-replicating persistence stage 1dosRassociated

0.556

Amp0.2mg/mL AmpicillincellWall

0.309

Cephalexin20-100 ug/mL CephalexincellWall

0.021

Cerulenin0.32-5 ug/mL CerulenincellWall

0.823

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.628

EMB10-20 ug/mL EthambutolcellWall

0.349

Eta12-40 ug/mL EthionamidecellWall

0.557

INH0.2-0.4 ug/mL IsoniazidcellWall

0.472

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.175

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.205

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.178

BZA0.12 mg/mL BenzamidearomaticAmides

-0.232

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.171

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.155

H2O24 mM hydrogen peroxideDNAdamaging

0.077

Levo10 ug/mL LevofloxacinDNAdamaging

0.325

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

2.933

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.249

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.629

UVUV-irradiationDNAdamaging

-0.762

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.001

Antimycin12.5-50 ug/mL Antimycin A?

-0.074

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.335

PA_110-50 ug/mL Antitubercular compound PA-1?

0.117

PA_2110-50 ug/mL Antitubercular compound PA-21?

0.156

PA8240.2-2 ug/mL PA-824?

-0.089

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.364

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.365

Verapamil50 uM Verapamil?

-0.564

mercaptoethanol2 mM 2-Mercaptoethanol?

0.036

methoxatin10-20 ug/mL Methoxatin?